Effect of nifedipine on myocardial metabolism in patients with unstable angina

L. I. Araujo, P. Camici, T. J. Spinks, T. Jones, A. Maseri

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Myocardial glucose metabolism was assessed using 18F-fluorodeoxyglucose and positron emission tomography in 6 normal volunteers, 7 patients with coronary artery disease and stable angina and 15 patients with unstable angina. All studies were carried out on resting, fasting patients. The patients were off treatment and had no evidence of acute myocardial necrosis or ischaemia. A second study investigated the myocardial glucose metabolism of 5 of the patients with unstable angina after treatment with oral nifedipine. In the first study, the metabolic rate for glucose (MRG) was found to be similar in patients with stable angina and normal volunteers (0.023 ± 0.032 vs 0.012 vs 0.008 μmol ml-1 min-1, P <0.42), whereas the MRG was significantly higher in patients with unstable angina compared with both that of normal volunteers and patients with stable angina (0.084 ± 0.047 μmol ml-1 min-1, P <0.001). In the second study, the MRG of all of the 5 patients with unstable angina studied after the administration of nifedipine was significantly reduced (P <0.05), but was still higher than that of the normal controls. The possibility of spontaneous metabolic changes cannot be excluded, but the consistent reduction of the MRG in all 5 patients after the administration of nifedipine suggests that nifedipine has a beneficial effect on myocardial metabolism that could be related to either an increase in myocardial blood flow or to a direct metabolic effect of nifedipine.

Original languageEnglish
Pages (from-to)9-13
Number of pages5
JournalEuropean Heart Journal
Volume8
Issue numberSUPPL. K
Publication statusPublished - 1987

Fingerprint

Unstable Angina
Nifedipine
Glucose
Stable Angina
Healthy Volunteers
Fluorodeoxyglucose F18
Positron-Emission Tomography
Coronary Artery Disease
Fasting
Necrosis
Ischemia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Araujo, L. I., Camici, P., Spinks, T. J., Jones, T., & Maseri, A. (1987). Effect of nifedipine on myocardial metabolism in patients with unstable angina. European Heart Journal, 8(SUPPL. K), 9-13.

Effect of nifedipine on myocardial metabolism in patients with unstable angina. / Araujo, L. I.; Camici, P.; Spinks, T. J.; Jones, T.; Maseri, A.

In: European Heart Journal, Vol. 8, No. SUPPL. K, 1987, p. 9-13.

Research output: Contribution to journalArticle

Araujo, LI, Camici, P, Spinks, TJ, Jones, T & Maseri, A 1987, 'Effect of nifedipine on myocardial metabolism in patients with unstable angina', European Heart Journal, vol. 8, no. SUPPL. K, pp. 9-13.
Araujo, L. I. ; Camici, P. ; Spinks, T. J. ; Jones, T. ; Maseri, A. / Effect of nifedipine on myocardial metabolism in patients with unstable angina. In: European Heart Journal. 1987 ; Vol. 8, No. SUPPL. K. pp. 9-13.
@article{d4a9f4c4e6e84d21bd3695b9b937fe0c,
title = "Effect of nifedipine on myocardial metabolism in patients with unstable angina",
abstract = "Myocardial glucose metabolism was assessed using 18F-fluorodeoxyglucose and positron emission tomography in 6 normal volunteers, 7 patients with coronary artery disease and stable angina and 15 patients with unstable angina. All studies were carried out on resting, fasting patients. The patients were off treatment and had no evidence of acute myocardial necrosis or ischaemia. A second study investigated the myocardial glucose metabolism of 5 of the patients with unstable angina after treatment with oral nifedipine. In the first study, the metabolic rate for glucose (MRG) was found to be similar in patients with stable angina and normal volunteers (0.023 ± 0.032 vs 0.012 vs 0.008 μmol ml-1 min-1, P <0.42), whereas the MRG was significantly higher in patients with unstable angina compared with both that of normal volunteers and patients with stable angina (0.084 ± 0.047 μmol ml-1 min-1, P <0.001). In the second study, the MRG of all of the 5 patients with unstable angina studied after the administration of nifedipine was significantly reduced (P <0.05), but was still higher than that of the normal controls. The possibility of spontaneous metabolic changes cannot be excluded, but the consistent reduction of the MRG in all 5 patients after the administration of nifedipine suggests that nifedipine has a beneficial effect on myocardial metabolism that could be related to either an increase in myocardial blood flow or to a direct metabolic effect of nifedipine.",
author = "Araujo, {L. I.} and P. Camici and Spinks, {T. J.} and T. Jones and A. Maseri",
year = "1987",
language = "English",
volume = "8",
pages = "9--13",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "SUPPL. K",

}

TY - JOUR

T1 - Effect of nifedipine on myocardial metabolism in patients with unstable angina

AU - Araujo, L. I.

AU - Camici, P.

AU - Spinks, T. J.

AU - Jones, T.

AU - Maseri, A.

PY - 1987

Y1 - 1987

N2 - Myocardial glucose metabolism was assessed using 18F-fluorodeoxyglucose and positron emission tomography in 6 normal volunteers, 7 patients with coronary artery disease and stable angina and 15 patients with unstable angina. All studies were carried out on resting, fasting patients. The patients were off treatment and had no evidence of acute myocardial necrosis or ischaemia. A second study investigated the myocardial glucose metabolism of 5 of the patients with unstable angina after treatment with oral nifedipine. In the first study, the metabolic rate for glucose (MRG) was found to be similar in patients with stable angina and normal volunteers (0.023 ± 0.032 vs 0.012 vs 0.008 μmol ml-1 min-1, P <0.42), whereas the MRG was significantly higher in patients with unstable angina compared with both that of normal volunteers and patients with stable angina (0.084 ± 0.047 μmol ml-1 min-1, P <0.001). In the second study, the MRG of all of the 5 patients with unstable angina studied after the administration of nifedipine was significantly reduced (P <0.05), but was still higher than that of the normal controls. The possibility of spontaneous metabolic changes cannot be excluded, but the consistent reduction of the MRG in all 5 patients after the administration of nifedipine suggests that nifedipine has a beneficial effect on myocardial metabolism that could be related to either an increase in myocardial blood flow or to a direct metabolic effect of nifedipine.

AB - Myocardial glucose metabolism was assessed using 18F-fluorodeoxyglucose and positron emission tomography in 6 normal volunteers, 7 patients with coronary artery disease and stable angina and 15 patients with unstable angina. All studies were carried out on resting, fasting patients. The patients were off treatment and had no evidence of acute myocardial necrosis or ischaemia. A second study investigated the myocardial glucose metabolism of 5 of the patients with unstable angina after treatment with oral nifedipine. In the first study, the metabolic rate for glucose (MRG) was found to be similar in patients with stable angina and normal volunteers (0.023 ± 0.032 vs 0.012 vs 0.008 μmol ml-1 min-1, P <0.42), whereas the MRG was significantly higher in patients with unstable angina compared with both that of normal volunteers and patients with stable angina (0.084 ± 0.047 μmol ml-1 min-1, P <0.001). In the second study, the MRG of all of the 5 patients with unstable angina studied after the administration of nifedipine was significantly reduced (P <0.05), but was still higher than that of the normal controls. The possibility of spontaneous metabolic changes cannot be excluded, but the consistent reduction of the MRG in all 5 patients after the administration of nifedipine suggests that nifedipine has a beneficial effect on myocardial metabolism that could be related to either an increase in myocardial blood flow or to a direct metabolic effect of nifedipine.

UR - http://www.scopus.com/inward/record.url?scp=0023603403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023603403&partnerID=8YFLogxK

M3 - Article

C2 - 3450526

AN - SCOPUS:0023603403

VL - 8

SP - 9

EP - 13

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - SUPPL. K

ER -